½ÃÀ庸°í¼­
»óǰÄÚµå
1598678

¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå : ±â¼ú, À¯Çü, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Traumatic Brain Injury Assessment & Management Devices Market by Technique (Intracranial Pressure (ICP) Monitoring, Partial Pressure of Oxygen In Brain Tissue (pBrO2)), Type (Imaging Devices, Monitoring Devices), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 194 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 37¾ï 7,000¸¸ ´Þ·¯·Î 2024³â¿¡´Â 41¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 9.45% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 71¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿Ü»ó¼º ³ú¼Õ»ó(TBI) Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå¿¡´Â TBIÀÇ Áø´Ü, ¸ð´ÏÅ͸µ, Ä¡·á¸¦ À§ÇÑ ´Ù¾çÇÑ ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ±â±âÀÇ ÁÖ¿ä Çʿ伺Àº ½ºÆ÷Ã÷ ¿Ü»ó, ±³Åë »ç°í, ³«»ó µîÀ¸·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î TBI ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½Å¼ÓÇϰí Á¤È®ÇÑ ºñħ½ÀÀû Áø´Ü µµ±¸ÀÇ Çʿ伺ÀÌ °­Á¶µÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±âÀÇ ¿ëµµ´Â Àû½Ã °³ÀÔÀÌ Áß¿äÇÑ º´¿ø ¹× Ŭ¸®´Ð¿¡¼­ ½ºÆ÷Ã÷ ÇöÀå ¹× ±º»ç ȯ°æ¿¡ À̸£±â±îÁö ´Ù¾çÇÕ´Ï´Ù. ÃÖÁ¾ »ç¿ë ºÐ¾ß¿¡´Â ÀÇ·á ½Ã¼³, ¿Ü·¡ Áø·á ¼¾ÅÍ, ¿¬±¸ ±â°ü, ½ºÆ÷Ã÷ ´Üü µîÀÌ Æ÷ÇԵ˴ϴÙ. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â AI¸¦ Ȱ¿ëÇÑ ¿µ»ó Áø´Ü µµ±¸¿Í °°Àº Áø´Ü ±â¼úÀÇ ¹ßÀü, TBI¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Á¤ºÎ Áö¿ø Á¤Ã¥, ÀÇ·áºñ Áõ°¡ µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ÇÑÆí, ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× ¿¹Ãø ºÐ¼®À» À§ÇÑ IoT¿Í AIÀÇ ÅëÇÕ, º¸´Ù Æø³ÐÀº Á¢±Ù¼ºÀ» À§ÇÑ ÈÞ´ë¿ë ¹× »ç¿ëÀÚ Ä£È­ÀûÀÎ µð¹ÙÀ̽º °³¹ß¿¡µµ »õ·Î¿î ±âȸ°¡ ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀå ¼ºÀåÀº ³ôÀº ±â±â ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, °í±Þ µµ±¸¸¦ Á¶ÀÛÇÒ ¼ö ÀÖ´Â ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ· µîÀÇ µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, TBIÀÇ ÀÌÁú¼ºÀº Ç¥ÁØÈ­µÈ Æò°¡ ÇÁ·ÎÅäÄÝÀÇ °³¹ßÀ» º¹ÀâÇÏ°Ô ¸¸µé°í ÀÖÀ¸¸ç, ÀÌ´Â ÇѰèÀÌÀÚ Çõ½ÅÀÇ ±âȸÀ̱⵵ ÇÕ´Ï´Ù. ±â¼ú Çõ½ÅÀÇ ÀáÀç·ÂÀÌ ÀÖ´Â Ä¡·á ºÐ¾ß¿¡´Â ¿þ¾î·¯ºí Áø´Ü ±â¼ú, ¸ÂÃãÇü Ä¡·á °èȹÀ» À§ÇÑ ±â°è ÇнÀ ¾Ë°í¸®Áò, ¿ø°Ý TBI °ü¸®¸¦ À§ÇÑ ¿ø°ÝÀÇ·á Ç÷§Æû, µµ½Ã¿Í ³óÃÌÀÇ ÀÇ·á °ÝÂ÷ ÇØ¼Ò¸¦ À§ÇÑ ¿ø°ÝÀÇ·á Ç÷§Æû µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Áß°£ Á¤µµÀ̸ç, ºü¸¥ ±â¼ú ¹ßÀü°ú ºó¹øÇÑ Á¦ÈÞ ¹× ÀμöÇÕº´ÀÌ Æ¯Â¡À̸ç, âÁ¶Àû ÆÄ±«ÀÇ ¿©Áö°¡ ÃæºÐÇÑ ¿ªµ¿ÀûÀÎ »óȲÀ» ¾Ï½ÃÇÕ´Ï´Ù. ±â¾÷µéÀº ÇÐ°è ¹× ÀÇ·á ±â°ü°úÀÇ ¿¬±¸°³¹ß¿¡ ÁýÁßÇÏ¿© ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ´Â µ¿½Ã¿¡ ºñ¿ë ¹× Á¢±Ù À庮À» ÇØ°áÇØ¾ß ÇÕ´Ï´Ù. ±â¼ú°ú Àü·«Àû ÆÄÆ®³Ê½ÊÀ» Ȱ¿ëÇϸé ÀÌÇØ°ü°èÀÚµéÀº »õ·Î¿î Æ®·»µå¸¦ Ȱ¿ëÇϰí ÀÌ Áß¿äÇÑ ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ¹ßÀÚÃ븦 È®ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 37¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 41¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 71¾ï ´Þ·¯
CAGR(%) 9.45%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ¿Ü»ó¼º ³ú¼Õ»ó À¯º´·ü »ó½Â
    • ÃÖ¼Òħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼ºÇâ
    • ÃÖ±Ù ¸î ³â µ¿¾È ÀÇ·á±â±â¿¡ ´ëÇÑ ¿©·¯ °¡Áö ½ÂÀÎ
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • °í±Þ Æò°¡ ¹× °ü¸® ±â±âÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • Á¦Ç° °³¼±À» À§ÇÑ R&D ÅõÀÚ
    • Àü ¼¼°è ÀÇ·á±â°üÀÇ ÀÎ½Ä Á¦°í ÇÁ·Î±×·¥ ¹× ÀÌ´Ï¼ÅÆ¼ºê
  • ½ÃÀå °úÁ¦
    • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·

Æ÷ÅÍÀÇ 5°¡Áö ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå °ø·«À» À§ÇÑ Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀü°úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ´Þ¼ºÇÒ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå : ±â¼úº°

  • µÎ°³³»¾Ð(ICP) ¸ð´ÏÅ͸µ
  • ³úÁ¶Á÷³» »ê¼Ò ºÐ¾Ð(pBrO2)

Á¦7Àå ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå : À¯Çüº°

  • ¿µ»ó ±â±â
  • ¸ð´ÏÅ͸µ ±â±â

Á¦8Àå ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Áø´Ü ¼¾ÅÍ
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • bioMerieux SA
  • BRAINBox Solutions, Inc.
  • BrainScope Company Inc.
  • Compumedics Limited
  • InfraScan, Inc.
  • Integra Lifesciences Corporation
  • Medtronic plc
  • NanoDx, Inc.
  • Natus Medical Incorporated
  • Optima Medical Ltd.
  • RAUMEDIC AG
  • Vivonics Inc.
  • Wolters Kluwer N.V.
ksm 24.11.29

The Traumatic Brain Injury Assessment & Management Devices Market was valued at USD 3.77 billion in 2023, expected to reach USD 4.12 billion in 2024, and is projected to grow at a CAGR of 9.45%, to USD 7.10 billion by 2030.

The traumatic brain injury (TBI) assessment and management devices market encompasses a wide range of technologies designed to diagnose, monitor, and treat TBIs. The primary necessity for these devices stems from the increasing global incidence of TBIs, driven by sports injuries, road accidents, and falls, emphasizing the need for rapid, accurate, and non-invasive diagnostic tools. Applications of these devices span from hospitals and clinics to sports settings and military environments, where timely intervention is crucial. End-use sectors prominently include healthcare facilities, ambulatory care centers, research institutions, and sports organizations. Key growth influencers include advancements in diagnostic technologies like AI-driven imaging tools, greater awareness about TBIs, supportive government policies, and increasing healthcare expenditure. Meanwhile, emerging opportunities lie in integrating IoT and AI for real-time monitoring and predictive analytics, as well as the development of portable, user-friendly devices for broader accessibility. However, market growth faces challenges such as high device costs, stringent regulatory requirements, and a shortage of skilled professionals to operate advanced tools. Furthermore, the heterogeneity of TBIs complicates the development of standardized assessment protocols, which presents both a limitation and an opportunity for innovation. Areas offering potential for innovation include wearable diagnostic technologies, machine learning algorithms for personalized treatment plans, and telemedicine platforms for remote TBI management, addressing both urban and rural healthcare disparities. The market is moderately competitive and characterized by rapid technological advancements and frequent partnerships and acquisitions, suggesting a dynamic landscape with ample room for disruption. Companies should focus on research and development collaborations with academic and medical institutions to foster innovation while also addressing cost and accessibility barriers. By leveraging technology and strategic partnerships, stakeholders can capitalize on emerging trends and expand their footprint in this vital healthcare segment.

KEY MARKET STATISTICS
Base Year [2023] USD 3.77 billion
Estimated Year [2024] USD 4.12 billion
Forecast Year [2030] USD 7.10 billion
CAGR (%) 9.45%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Traumatic Brain Injury Assessment & Management Devices Market

The Traumatic Brain Injury Assessment & Management Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of traumatic brain injuries
    • Inclination towards minimally invasive procedures
    • Several approvals for the devices in recent years
  • Market Restraints
    • High cost of advanced assessment & management devices
  • Market Opportunities
    • R&D investment for product advancement
    • Awareness programs and initiatives by healthcare organizations across the globe
  • Market Challenges
    • Shortage of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Traumatic Brain Injury Assessment & Management Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Traumatic Brain Injury Assessment & Management Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Traumatic Brain Injury Assessment & Management Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Traumatic Brain Injury Assessment & Management Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Traumatic Brain Injury Assessment & Management Devices Market

A detailed market share analysis in the Traumatic Brain Injury Assessment & Management Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Traumatic Brain Injury Assessment & Management Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Traumatic Brain Injury Assessment & Management Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Traumatic Brain Injury Assessment & Management Devices Market

A strategic analysis of the Traumatic Brain Injury Assessment & Management Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Traumatic Brain Injury Assessment & Management Devices Market, highlighting leading vendors and their innovative profiles. These include bioMerieux SA, BRAINBox Solutions, Inc., BrainScope Company Inc., Compumedics Limited, InfraScan, Inc., Integra Lifesciences Corporation, Medtronic plc, NanoDx, Inc., Natus Medical Incorporated, Optima Medical Ltd., RAUMEDIC AG, Vivonics Inc., and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Traumatic Brain Injury Assessment & Management Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technique, market is studied across Intracranial Pressure (ICP) Monitoring and Partial Pressure of Oxygen In Brain Tissue (pBrO2).
  • Based on Type, market is studied across Imaging Devices and Monitoring Devices.
  • Based on End User, market is studied across Diagnostic Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of traumatic brain injuries
      • 5.1.1.2. Inclination towards minimally invasive procedures
      • 5.1.1.3. Several approvals for the devices in recent years
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced assessment & management devices
    • 5.1.3. Opportunities
      • 5.1.3.1. R&D investment for product advancement
      • 5.1.3.2. Awareness programs and initiatives by healthcare organizations across the globe
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Traumatic Brain Injury Assessment & Management Devices Market, by Technique

  • 6.1. Introduction
  • 6.2. Intracranial Pressure (ICP) Monitoring
  • 6.3. Partial Pressure of Oxygen In Brain Tissue (pBrO2)

7. Traumatic Brain Injury Assessment & Management Devices Market, by Type

  • 7.1. Introduction
  • 7.2. Imaging Devices
  • 7.3. Monitoring Devices

8. Traumatic Brain Injury Assessment & Management Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals

9. Americas Traumatic Brain Injury Assessment & Management Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Traumatic Brain Injury Assessment & Management Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Traumatic Brain Injury Assessment & Management Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. bioMerieux SA
  • 2. BRAINBox Solutions, Inc.
  • 3. BrainScope Company Inc.
  • 4. Compumedics Limited
  • 5. InfraScan, Inc.
  • 6. Integra Lifesciences Corporation
  • 7. Medtronic plc
  • 8. NanoDx, Inc.
  • 9. Natus Medical Incorporated
  • 10. Optima Medical Ltd.
  • 11. RAUMEDIC AG
  • 12. Vivonics Inc.
  • 13. Wolters Kluwer N.V.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦